drugset / Trial / NCT02143518
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Na-GST-1 is a protein expressed during the adult stage of the hookworm life cycle that is thought to play a role in the parasite's degradation of host hemoglobin for use as an energy source. Vaccination with recombinant GST-1 has protected dogs and hamsters from infection in challenge studies. This study will evaluate the safety and immunogenicity of two formulations of Na-GST-1 in healthy adult volunteers when co-administered with the immunostimulant CpG 10104, a Toll-like Receptor-9 agonist.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-06
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Na-GST-1 | Protein / enzyme biologic | 30 ug | Intramuscular |
| Subject | Na-GST-1 | Protein / enzyme biologic | 100 ug | Intramuscular |
| Subject | agatolimod | Oligonucleotide (other) | 500 ug | Intramuscular |